By John Carroll - FierceBiotech
Susan Desmond-Hellmann is pushing to make the University of California, San Francisco an international powerhouse in the world of drug discovery. Profiled in an in-depth article in The New York Times, the former Genentech exec is turning the university’s Mission Bay campus into a biotech empire, with major federal funding for translational research work and a string of new collaborations planned for the development upstarts that call the Bay Area home.
